Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the pricing of 14,130,436 shares of ...
Bill Graber left hundreds of artworks behind when he moved out of state, columnist David Allen writes. An open house and a museum show are planned to hail him in his absence.